Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis - Phase 2|Phase 3 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- Wake Forest University Health Sciences|Emory University|University of Minnesota|University of Texas Southwestern Medical Center
The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis â on the search for means of improvement
ongoing trials trial from other registries
Details- 2022
Evaluation the effects of camel milk in spirometry parameters in over 6 yearâs children with Cystic Fibrosis lung disease - Recruiting
ongoing trials trial from other registries
Details- 2022
Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis - Phase 2 - Recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- University of Kansas Medical Center
Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation - Phase 3 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- Vertex Pharmaceuticals Incorporated
Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF - Phase 4 - Recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- Hospital Infantil de Mexico Federico Gomez
A Phase 3 Open-label Study Evaluating the Longterm Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects With Non-F508del CFTR Genotypes
ongoing trials trial from other registries
Details- 2021
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
ongoing trials trial from other registries
Details- 2021
A Phase 3 Double-blind, Randomized, Placebo-controlled Study Evaluating the Efficacy and Safety of ELX/TEZ/IVA in Cystic Fibrosis Subjects 6 Years of Age and Older With a Non-F508del ELX/TEZ/IVA-responsive CFTR Mutation
ongoing trials trial from other registries
Details- 2021
CYstic Fibrosis bacterioPHage Study at Yale (CYPHY) - Phase 1|Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2021
- Yale University